一项2026年的小型试验发现,在耐治疗的成年人中,DMT疗法迅速减少抑郁症症状达六个月。 A small 2026 trial found DMT therapy rapidly reduced depression symptoms for up to six months in treatment-resistant adults.

对34名患有抗治疗性抑郁症的成年人进行了2026年临床小试验,结果发现,一次性静脉注射剂量DMT与治疗相结合,导致症状迅速和持续减少,持续时间可达六个月,第二剂没有额外好处。 A small 2026 clinical trial of 34 adults with treatment-resistant depression found that a single intravenous dose of DMT, combined with therapy, led to rapid and sustained reductions in symptoms lasting up to six months, with no added benefit from a second dose. 参与者显示,与安慰剂相比,抑郁程度有了显著改善,在短短的25分钟精神错乱过程中,其影响与深刻的神秘经历有关。 Participants showed significant improvement on depression scales compared to placebo, with effects linked to intense mystical experiences during the brief 25-minute psychedelic episode. 副作用是轻微和暂时的。 Side effects were mild and temporary. 虽然结果很有希望,但研究人员强调,在可能获得批准之前,需要进行更大规模、更多样化的试验,以确认安全性、功效和长期结果。 While results are promising, researchers emphasize the need for larger, more diverse trials to confirm safety, efficacy, and long-term outcomes before potential approval.